The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReneuron Share News (RENE)

  • This share is currently suspended. It was suspended at a price of 3.275

Share Price Information for Reneuron (RENE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.275
RENE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director dealings: Reneuron Group non-executive makes share purchase

Thu, 21st Oct 2021 16:40

(Sharecast News) - Reneuron Group revealed on Thursday that non-executive director Barbara Staehelin had acquired 43,000 ordinary shares in the AIM-listed cell-based therapeutics developer.
Staehelin, who was appointed as senior independent director at ReNeuron back in July, purchased the shares on Wednesday at an average price of 115.0p each, for a total value of £49,450 each.

Earlier in the week, Reneuron Group said that the first UK subject had been treated at the Oxford Eye Hospital as part of its phase 2a clinical evaluations for the treatment of retinitis pigmentosa (RP) - an inherited, degenerative eye disease.

As of 1640 BST, Reneuron shares were up 0.88% at 115.0p each.

Top Director Buys

Jupiter Fund Management (JUP)
Director name: Formica,Andrew
Amount purchased: 360,413 @ 248.41p
Value: £895,301.97

Reneuron Group (RENE)
Director name: Staehelin,Barbara
Amount purchased: 43,000 @ 115.00p
Value: £49,450.00

Emis Group (EMIS)
Director name: Collis,Denise
Amount purchased: 1,441 @ 1,379.58p
Value: £19,879.75

Golden Prospect Precious Metals Ltd. (GPM)
Director name: Burne,Malcolm Alec
Amount purchased: 25,000 @ 46.00p
Value: £11,500.00

Dialight (DIA)
Director name: Oliver,Karen
Amount purchased: 2,698 @ 367.00p
Value: £9,901.66

Dialight (DIA)
Director name: Haug ,Gotthard
Amount purchased: 2,500 @ 369.75p
Value: £9,243.75

Audioboom Group (BOOM)
Director name: Tobin,Michael
Amount purchased: 140 @ 1,030.00p
Value: £1,442.00

Homeserve (HSV)
Director name: Rusin,Tom
Amount purchased: 20 @ 832.50p
Value: £166.50

Homeserve (HSV)
Director name: Harpin,Richard
Amount purchased: 19 @ 832.50p
Value: £158.17

Homeserve (HSV)
Director name: Bower,David
Amount purchased: 19 @ 832.50p
Value: £158.17



Top Director Sells

Jupiter Fund Management (JUP)
Director name: Formica,Andrew
Amount sold: 360,413 @ 248.40p
Value: £895,265.88

Vertu Motors (VTU)
Director name: Crane,David
Amount sold: 281,916 @ 62.45p
Value: £176,056.54

Vertu Motors (VTU)
Director name: Anderson,Karen
Amount sold: 281,916 @ 62.45p
Value: £176,056.54

Capital Limited (di) (CAPD)
Director name: Abery,David
Amount sold: 17,715 @ 84.00p
Value: £14,880.60

More News
10 Sep 2020 16:01

UK TRADING UPDATE SUMMARY: Prime People Hurt As Covid Hits Job Market

UK TRADING UPDATE SUMMARY: Prime People Hurt As Covid Hits Job Market

Read more
3 Sep 2020 16:06

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
12 Aug 2020 13:35

IN BRIEF: ReNeuron Adds Obotritia Rep To Board; Names New Chair

IN BRIEF: ReNeuron Adds Obotritia Rep To Board; Names New Chair

Read more
31 Jul 2020 16:22

ReNeuron gets patent allowance in the US

(Sharecast News) - Cell-based therapeutics developer ReNeuron Group announced on Friday that the US Patent and Trademark office (USPTO) has completed its examination of its application titled 'phenotype profile of human retinal progenitor cells', and has issued a notification of allowance for the issue of a patent.

Read more
31 Jul 2020 11:28

UK WINNERS & LOSERS SUMMARY: Pets At Home Up 15% On June Sales Bounce

UK WINNERS & LOSERS SUMMARY: Pets At Home Up 15% On June Sales Bounce

Read more
29 Jun 2020 20:39

IN BRIEF: ReNeuron Posts Encouraging Data On Eye Condition Treatment

IN BRIEF: ReNeuron Posts Encouraging Data On Eye Condition Treatment

Read more
25 Jun 2020 14:55

IN BRIEF: ReNeuron Signs Exosome Research Collaboration With US Firm

IN BRIEF: ReNeuron Signs Exosome Research Collaboration With US Firm

Read more
25 Jun 2020 11:22

ReNeuron Group inks research evaluation deal with US firm

(Sharecast News) - Cell-based therapeutics company ReNeuron Group announced on Thursday that it has signed a new research evaluation agreement with a major United States biotechnology company, in connection with the use of its proprietary exosomes for the delivery of novel gene silencing therapeutics.

Read more
17 Jun 2020 15:58

IN BRIEF: ReNeuron Gets Approval In US And UK For Expanded Drug Trial

IN BRIEF: ReNeuron Gets Approval In US And UK For Expanded Drug Trial

Read more
3 Apr 2020 11:41

UK TRADING UPDATE SUMMARY: Bagir Says Cash Insufficient To Carry On

UK TRADING UPDATE SUMMARY: Bagir Says Cash Insufficient To Carry On

Read more
24 Feb 2020 12:24

Positive hRPC Stem Cell Trial Data Prompts ReNeuron To Expand Study

Positive hRPC Stem Cell Trial Data Prompts ReNeuron To Expand Study

Read more
17 Feb 2020 10:29

Data From ReNeuron CTX Stem Cell Therapy Trial Published In Journal

Data From ReNeuron CTX Stem Cell Therapy Trial Published In Journal

Read more
18 Dec 2019 19:08

Woodford Transfers Series Of Holdings To New Manager Schroders

Woodford Transfers Series Of Holdings To New Manager Schroders

Read more
6 Dec 2019 10:42

ReNeuron cuts losses after Fosun licence payment

(Sharecast News) - ReNeuron Group on Friday reported a narrower interim loss after receiving payment from a Chinese licensee, while it also made progress in its clinical and research programmes.

Read more
6 Dec 2019 09:32

ReNeuron Reports "Strong Progress" Across Various Programmes

ReNeuron Reports "Strong Progress" Across Various Programmes

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.